Follow
Ron M. Kerkhoven
Ron M. Kerkhoven
Retired Associated Scientist, Netherlands Cancer Institute
No verified email
Title
Cited by
Cited by
Year
Gene expression profiling predicts clinical outcome of breast cancer
LJ Van't Veer, H Dai, MJ Van De Vijver, YD He, AAM Hart, M Mao, ...
nature 415 (6871), 530-536, 2002
117522002
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
K Berns, EM Hijmans, J Mullenders, TR Brummelkamp, A Velds, ...
Nature 428 (6981), 431-437, 2004
14662004
Systematic protein location mapping reveals five principal chromatin types in Drosophila cells
GJ Filion, JG van Bemmel, U Braunschweig, W Talhout, J Kind, LD Ward, ...
Cell 143 (2), 212-224, 2010
11352010
Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation
D Peric-Hupkes, W Meuleman, L Pagie, SWM Bruggeman, I Solovei, ...
Molecular cell 38 (4), 603-613, 2010
11052010
Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma
N van Rooij, MM van Buuren, D Philips, A Velds, M Toebes, B Heemskerk, ...
Journal of clinical oncology: official journal of the American Society of …, 2013
9402013
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili, MRH Kooistra, A Brás, J Kauw, RM Kerkhoven, A Morrison, ...
Nature cell biology 7 (2), 126-136, 2005
9052005
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway
SMB Nijman, TT Huang, AMG Dirac, TR Brummelkamp, RM Kerkhoven, ...
Molecular cell 17 (3), 331-339, 2005
6822005
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
X Liu, H Holstege, H van der Gulden, M Treur-Mulder, J Zevenhoven, ...
Proceedings of the National Academy of Sciences 104 (29), 12111-12116, 2007
5192007
E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.
RL Beijersbergen, RM Kerkhoven, L Zhu, L Carlée, PM Voorhoeve, ...
Genes & development 8 (22), 2680-2690, 1994
4811994
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
B Pang, X Qiao, L Janssen, A Velds, T Groothuis, R Kerkhoven, ...
Nature communications 4 (1), 1908, 2013
4312013
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
RL Beijersbergen, L Carlée, RM Kerkhoven, R Bernards
Genes & development 9 (11), 1340-1353, 1995
3691995
Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry
LT Jae, M Raaben, M Riemersma, E Van Beusekom, VA Blomen, A Velds, ...
Science 340 (6131), 479-483, 2013
3002013
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment
AM Glas, MJ Kersten, LJMJ Delahaye, AT Witteveen, RE Kibbelaar, ...
Blood 105 (1), 301-307, 2005
2952005
One naive T cell, multiple fates in CD8+ T cell differentiation
C Gerlach, JW Van Heijst, E Swart, D Sie, N Armstrong, RM Kerkhoven, ...
Journal of Experimental Medicine 207 (6), 1235-1246, 2010
2842010
Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.
G Hateboer, RM Kerkhoven, A Shvarts, R Bernards, RL Beijersbergen
Genes & development 10 (23), 2960-2970, 1996
2791996
Gene expression profiling predicts clinical outcome of breast cancer
V Van't, J Laura, H DAI, GJ SCHREIBER, RM KERKHOVEN, C ROBERTS, ...
Nature (London) 415 (6871), 530-536, 2002
2622002
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp, AWM Fabius, J Mullenders, M Madiredjo, A Velds, ...
Nature chemical biology 2 (4), 202-206, 2006
2582006
BRD7 is a candidate tumour suppressor gene required for p53 function
J Drost, F Mantovani, F Tocco, R Elkon, A Comel, H Holstege, ...
Nature cell biology 12 (4), 380-389, 2010
2342010
High-throughput identification of antigen-specific TCRs by TCR gene capture
C Linnemann, B Heemskerk, P Kvistborg, RJC Kluin, DA Bolotin, X Chen, ...
Nature medicine 19 (11), 1534-1541, 2013
2182013
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
EA Rozeman, EP Hoefsmit, ILM Reijers, RPM Saw, JM Versluis, ...
Nature medicine 27 (2), 256-263, 2021
2172021
The system can't perform the operation now. Try again later.
Articles 1–20